187 related articles for article (PubMed ID: 9443305)
1. The role of Pseudomonas aeruginosa in the pathogenesis of lung disease in cystic fibrosis: more questions than answers.
Kerem E
Pediatr Pulmonol Suppl; 1997; 16():265-6. PubMed ID: 9443305
[No Abstract] [Full Text] [Related]
2. Pseudomonas aeruginosa in cystic fibrosis is potentially serious, and more than merely a marker for disease severity.
Lenney W
Paediatr Respir Rev; 2015 Oct; 16 Suppl 1():35-6. PubMed ID: 26410280
[No Abstract] [Full Text] [Related]
3. Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation?
Stressmann FA; Rogers GB; Marsh P; Lilley AK; Daniels TW; Carroll MP; Hoffman LR; Jones G; Allen CE; Patel N; Forbes B; Tuck A; Bruce KD
J Cyst Fibros; 2011 Sep; 10(5):357-65. PubMed ID: 21664196
[TBL] [Abstract][Full Text] [Related]
4. Application of quantitative PCR to the diagnosis and monitoring of Pseudomonas aeruginosa colonization in 5-18-year-old cystic fibrosis patients.
Billard-Pomares T; Herwegh S; Wizla-Derambure N; Turck D; Courcol R; Husson MO
J Med Microbiol; 2011 Feb; 60(Pt 2):157-161. PubMed ID: 20947668
[TBL] [Abstract][Full Text] [Related]
5. Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection.
Quittner AL; Modi AC; Wainwright C; Otto K; Kirihara J; Montgomery AB
Chest; 2009 Jun; 135(6):1610-1618. PubMed ID: 19447923
[TBL] [Abstract][Full Text] [Related]
6. Effective strategies for managing new Pseudomonas cultures in adults with cystic fibrosis.
Ali H; Orchard C; Mariveles M; Scott S; Alshafi K; Bilton D; Simmonds N
Eur Respir J; 2015 Sep; 46(3):862-5. PubMed ID: 25882803
[No Abstract] [Full Text] [Related]
7. Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response.
Lam JC; Somayaji R; Surette MG; Rabin HR; Parkins MD
BMC Infect Dis; 2015 Mar; 15():145. PubMed ID: 25887462
[TBL] [Abstract][Full Text] [Related]
8. [Nocardia farcinica infection in a patient with cystic fibrosis].
Beucher J; Belleguic C; Brinchault G; Deneuville E; Donnio PY; Roussey M
Rev Mal Respir; 2010; 27(1):76-9. PubMed ID: 20146956
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary infection in mild variant cystic fibrosis: implications for care.
Lording A; McGaw J; Dalton A; Beal G; Everard M; Taylor CJ
J Cyst Fibros; 2006 May; 5(2):101-4. PubMed ID: 16426904
[TBL] [Abstract][Full Text] [Related]
10. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
Jain K; Wainwright C; Smyth AR
Cochrane Database Syst Rev; 2013 Dec; (12):CD009530. PubMed ID: 24363033
[TBL] [Abstract][Full Text] [Related]
11. Open label study of inhaled aztreonam for Pseudomonas eradication in children with cystic fibrosis: The ALPINE study.
Tiddens HA; De Boeck K; Clancy JP; Fayon M; H G M A; Bresnik M; Derchak A; Lewis SA; Oermann CM;
J Cyst Fibros; 2015 Jan; 14(1):111-9. PubMed ID: 25091537
[TBL] [Abstract][Full Text] [Related]
12. [Chronic Pseudomonas aeruginosa airway colonization in cystic fibrosis patients : Prevention concepts].
Dittrich AM
Internist (Berl); 2017 Nov; 58(11):1133-1141. PubMed ID: 28963697
[TBL] [Abstract][Full Text] [Related]
13. Eradication of Pseudomonas aeruginosa in cystic fibrosis.
Eber E; Thalhammer GH; Zach MS
Eur Respir J; 2006 Feb; 27(2):438-9. PubMed ID: 16452606
[No Abstract] [Full Text] [Related]
14. Cystic fibrosis epithelial cell and bacterial binding.
Engel J; Matthay M
Am J Physiol Lung Cell Mol Physiol; 2013 Dec; 305(11):L891. PubMed ID: 24310120
[No Abstract] [Full Text] [Related]
15. Cystic fibrosis epithelial cell and bacterial binding.
Dosanjh A
Am J Physiol Lung Cell Mol Physiol; 2013 Dec; 305(11):L890. PubMed ID: 24310119
[No Abstract] [Full Text] [Related]
16. Precipitating Pseudomonas aeruginosa antibodies and antimicrobial therapy in cystic fibrosis patients.
Trancassini M; de Vito D; Cimino G; Antonelli M; Quattrucci S; Cipriani P
Eur J Clin Microbiol Infect Dis; 1996 Apr; 15(4):309-12. PubMed ID: 8781882
[TBL] [Abstract][Full Text] [Related]
17. Carbenicillin treatment of Pseudomonas pulmonary infection. Use in children with cystic fibrosis.
Phair JP; Tan JS; Watanakunakorn C; Schwab L; Sanders LW
Am J Dis Child; 1970 Jul; 120(1):22-5. PubMed ID: 4316325
[No Abstract] [Full Text] [Related]
18. Treatment of lung infection in patients with cystic fibrosis: current and future strategies.
Döring G; Flume P; Heijerman H; Elborn JS;
J Cyst Fibros; 2012 Dec; 11(6):461-79. PubMed ID: 23137712
[TBL] [Abstract][Full Text] [Related]
19. PCR and the detection of Pseudomonas aeruginosa in respiratory samples of CF patients. A literature review.
Deschaght P; Van Daele S; De Baets F; Vaneechoutte M
J Cyst Fibros; 2011 Sep; 10(5):293-7. PubMed ID: 21684819
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa colonization in the upper and lower airways of a child with cystic fibrosis: a father's meticulous approach to successful eradication.
Mainz JG; Baier M; Jaudszus A; Tabori H; Ribeiro JD; Lorenz M
J Bras Pneumol; 2019 Oct; 45(6):e20190191. PubMed ID: 31618301
[No Abstract] [Full Text] [Related]
[Next] [New Search]
